Eric Abrams

teaching claude science @AnthropicAI

[Eric Abrams @eric_kabrams]

@ImmunoFever @claudeai dm me if you’re having trouble, I’ll help get this resolved asap

[Eric Abrams @eric_kabrams]

@aaronmring we are working literally as hard as we can to make this happen. Please hang on a little longer.

[Eric Abrams @eric_kabrams]

We’re also expanding the scale of our AI for Science program, with large-scale tokens grants for researchers working on high-impact projects.

Meanwhile, we continue to increase the scale of our bio efforts, and I expect to share more on this soon.

[Eric Abrams @eric_kabrams]

Our models are now capable of accelerating many aspects of scientific research. I’ve been having endless fun pointing Claude at problems I’ve always cared about, and in some cases watching it make progress for the first time.

Today, we’re expanding our focus beyond bio to include support for every scientific discipline. We’re launching a new plan for scientists and are making an initial 10,000 seats available for free and at heavily discounted rates.

[Claude @claudeai]

Starting today, 10,000 scientists across every field, from math to chemistry to physics and more, can get Claude through our new Claude Team plan for scientists. Standard seats are free, and premium seats with 5x usage limits are $15 per month, an 80% discount, for one year.

Claude is becoming increasingly capable of scientific work, with recent progress on problems from advanced physics calculations to protein design. Alongside that progress, we've been investing in the research community: Claude Science launched in June, and our AI for Science program funds high-impact projects with free credits. Today's expansion builds on both.

Principal investigators (or equivalent) at academic and nonprofit research institutions can sign up, then add the researchers in their group. Over the coming months, we plan to extend the program well beyond the initial 10,000 seats.

Learn more: https://t.co/RTG1JxWi4Q

[Eric Abrams @eric_kabrams]

Finally, it is among our team's highest priorities to make our most capable models available to the scientific community for biology research, and we expect to share more on this soon.

[Eric Abrams @eric_kabrams]

Today we shared an update on Claude’s capabilities in protein design and analytical chemistry. These works illustrate something that is often glossed over: we want Claude to do the task end-to-end, whatever that entails. Today, this includes selecting from and using specialized models as tools. In the future, this may include Claude deciding to train its own specialized models.

In the case of binder design, Claude selects from the best structure and design models available. As a human would, we see Claude stitch specialized model calls together, inspect the design, tweak some things, think about it more, and try again until satisfied. On many of the targets we tried, Claude’s results are competitive with the best that have been achieved previously.

[Anthropic @AnthropicAI]

Many drugs work by binding to a specific target in the body and blocking or changing what it does. An important first step in the drug development process is designing a molecule that can bind tightly to its target. Traditionally, that's meant weeks or months of expert work per target, sifting through a large number of candidates to identify the few that work.

We wanted to test if Claude could successfully design novel protein binders from scratch (also called de novo design). With a protein design prompt written by a human expert, Claude autonomously designed protein binders against 14 out of 15 targets.

We then worked with Adaptyv Bio and Twist Bioscience, who independently built and tested the proteins Claude designed.

[Eric Abrams @eric_kabrams]

There is much more that goes into developing a molecule with drug-like properties, and we’re continuing this work so that Claude can perform all of it, with established modalities like antibodies and small molecules.

And these tasks are themselves just one small part of our larger efforts to speed up drug development end-to-end, many aspects of which have more to do with policy and operational bottlenecks.

[Eric Abrams @eric_kabrams]

I've always been drawn to solving science and engineering problems to benefit people. Throughout my career, it has been an honor to partner with the federal government in these pursuits. The ability to express reasonable disagreement with our government, without untoward retaliation, is part of the fabric of American society, and is part of what makes our technology development environment the best in the world. I'm hopeful that we can continue doing important work with our federal government partners, and I'm proud to be part of the Anthropic team.

[Anthropic @AnthropicAI]

A statement on the comments from Secretary of War Pete Hegseth.

https://t.co/Gg7Zb09IMR

[Eric Abrams @eric_kabrams]

fare thee well, San Geraldo

[Eric Abrams @eric_kabrams]

@eshear Essays on Life Itself - Robert Rosen
https://t.co/iUzn5HKGI2